
Ophthalmologists are once again at the forefront of innovation for
cosmetic facial procedures. From Botox® to Juvéderm®, eye physicians
have been regarded as the experts in the original research and
development of injectable, anti-wrinkle treatments. Now, Latisse™,
the first and only FDA-approved treatment for inadequate or sparse,
thinning eyelashes, has been added to the options for facial
enhancement. Its origin is directly from a glaucoma medication that
ophthalmologists have been using for the treatment of elevated eye
pressure.